The Goldman Sachs Group Issues Pessimistic Forecast for Keurig Dr Pepper (NASDAQ:KDP) Stock Price

Key Points

• The Goldman Sachs Group has lowered its price target for Keurig Dr Pepper (NASDAQ:KDP) from $34.00 to $29.00 while maintaining a "neutral" rating, indicating a potential upside of 13.93% from the stock's previous close.
• Multiple analysts have issued various price targets for Keurig Dr Pepper; Jefferies set it at $41.00, while Barclays reduced theirs significantly to $26.00, highlighting varied sentiment among financial institutions.
• Keurig Dr Pepper's stock has seen a recent decline of 0.6%, closing at $25.46, with a 52-week trading range from $25.27 to $37.27.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) had its price target decreased by equities research analysts at The Goldman Sachs Group from $34.00 to $29.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. The Goldman Sachs Group's price objective points to a potential upside of 13.93% from the stock's previous close.

Other analysts have also issued reports about the stock. Jefferies Financial Group set a $41.00 price target on shares of Keurig Dr Pepper in a research report on Monday, August 25th. UBS Group decreased their price target on shares of Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating on the stock in a research report on Wednesday, August 27th. Barclays lowered shares of Keurig Dr Pepper from an "overweight" rating to an "equal weight" rating and decreased their price target for the stock from $39.00 to $26.00 in a research report on Wednesday, September 24th. HSBC restated a "hold" rating and issued a $30.00 price target (down from $42.00) on shares of Keurig Dr Pepper in a research report on Tuesday, August 26th. Finally, Hsbc Global Res lowered shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, August 26th. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Keurig Dr Pepper has an average rating of "Hold" and an average price target of $35.14.

Keurig Dr Pepper Stock Down 0.6%

Shares of Keurig Dr Pepper stock traded down $0.15 during midday trading on Thursday, reaching $25.46. 4,715,732 shares of the company's stock traded hands, compared to its average volume of 13,736,814. The company has a market cap of $34.58 billion, a price-to-earnings ratio of 22.73, a price-to-earnings-growth ratio of 1.40 and a beta of 0.43. The company's 50 day simple moving average is $30.47 and its 200 day simple moving average is $32.63. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64. Keurig Dr Pepper has a 52 week low of $25.27 and a 52 week high of $37.27.

Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $4.16 billion for the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The business's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.45 EPS. Equities analysts expect that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.

Insider Activity at Keurig Dr Pepper

In other news, insider Mary Beth Denooyer sold 12,000 shares of the business's stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider owned 82,511 shares of the company's stock, valued at $2,777,320.26. The trade was a 12.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert James Gamgort sold 208,000 shares of the company's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the completion of the sale, the director owned 2,292,169 shares of the company's stock, valued at approximately $75,412,360.10. This represents a 8.32% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 435,601 shares of company stock worth $14,421,512 in the last three months. 0.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Keurig Dr Pepper

Hedge funds have recently modified their holdings of the business. Rise Advisors LLC bought a new stake in Keurig Dr Pepper during the 1st quarter worth approximately $25,000. ST Germain D J Co. Inc. bought a new stake in shares of Keurig Dr Pepper during the first quarter worth $27,000. NewSquare Capital LLC raised its holdings in shares of Keurig Dr Pepper by 94.1% during the second quarter. NewSquare Capital LLC now owns 796 shares of the company's stock worth $26,000 after acquiring an additional 386 shares during the period. Chung Wu Investment Group LLC bought a new stake in Keurig Dr Pepper in the 2nd quarter valued at $26,000. Finally, AlphaCore Capital LLC acquired a new position in Keurig Dr Pepper in the 2nd quarter worth $26,000. Institutional investors and hedge funds own 93.99% of the company's stock.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.